Photo of Aimee Lucas

Aimee Lucas

  • ASSISTANT PROFESSOR Medicine, Gastroenterology
Print ProfilePrint Profile

Specialty

Certifications

  • Gastroenterology

  • American Board of Internal Medicine

Education

  • MD, Yale School of Medicine

  • ScB, Brown University

  • Residency, Internal Medicine
    Columbia University

  • Fellowship, Gastroenterology
    Columbia University College of Physicians & Surgeons

Biography

    Aimee L. Lucas MD, MS is Assistant Professor of Medicine in the Henry D. Janowitz Division of Gastroenterology at the Icahn School of Medicine at Mount Sinai. Her clinical practice encompasses the full spectrum of digestive disorders and endoscopy, with particular interest in caring for patients with hereditary cancer syndromes and those at high risk for developing gastrointestinal cancers, including pancreatic cancer.

    Her research interest is in developing screening regimens to detect early pancreatic cancer and precancerous lesions in high-risk patients with family history of pancreatic cancer or genetic cancer syndromes. Her work has been published in numerous gastroenterology and oncology journals, and she is a recipient of the NIH KL2 Translational Faculty Research Scholar Award.

    Dr. Lucas received her undergraduate degree from Brown University with Honors. She then received her medical degree from Yale University School of Medicine and completed a Howard Hughes Medical Institute Research Fellowship. She subsequently trained in Internal Medicine at NewYork-Presbyterian Hospital/Columbia University where she served as Chief Medical Resident. She remained at Columbia for fellowship training in Gastroenterology, during which time she served as Chief Gastroenterology Fellow and also obtained a Masters Degree in Patient-Oriented Research from the Mailman School of Public Health at Columbia University. She is board certified in Internal Medicine and Gastroenterology.

Awards

  • 2011 -
    Chief Gastroenterology Fellow, Division of Digestive and Liver Diseases, Columbia University College of Physicians & Surgeons

  • 2010 -
    Full Scholarship for Masters Degree in Patient Oriented Research at Columbia University Mailman School of Public Health

  • 2008 -
    Chief Medical Resident, Department of Medicine, Columbia University College of Physicians & Surgeons

  • 2007 -
    Second Annual American Gastroenterological Association Institute Investing in the Future: Promoting Diversity in GI Training

  • 2007 -
    Jay I. Meltzer/Rudin Foundation Medical Ethics Fellow.

  • 2005 -
    The Dr. Harold H. Lamport Biomedical Research Prize, Yale University School of Medicine

  • 2005 -
    Janet M. Gasgow Memorial Achievement Citation, Yale University School of Medicine

  • 2004 -
    American Society of Hematology Scholar Award

  • 2004 -
    Howard Hughes Medical Institute Research Training Fellowship for Medical Students: Continued Support for Completion of Medical Studies

  • 2004 -
    Farr Award, Yale University Student Research Day

  • 2003 -
    Howard Hughes Medical Institute Research Training Fellowship for Medical Students

  • 2000 -
    Honors in Biological Sciences, Brown University

  • 1999 -
    Sigma Xi

Publications

Lucas AL, Frado LE, Hwang C, Kumar S, Khanna LG, Levinson EJ, Chabot JA, Chung WK, Frucht H. BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts. Cancer 2014 Jul; 120(13).

Matloff J, Lucas AL, Polydorides AD, Itzkowitz SH. Molecular tumor testing for Lynch syndrome in patients with colorectal cancer. Journal of the National Comprehensive Cancer Network 2013 Nov; 11(11).

Lucas AL, Shakya R, Lipsyc MD, Mitchel EB, Kumar S, Hwang C, Deng L, Devoe C, Chabot JA, Szabolcs M, Ludwig T, Chung WK, Frucht H. High prevalence of BRCA1 and BRCA2 germline mutations with loss of heterozygosity in a series of resected pancreatic adenocarcinoma and other neoplastic lesions. Clinical cancer research 2013 Jul; 19(13).

Lucas AL, Chang MM, Lipsyc MD, Frucht H. The prevention and genetics of pancreatic cancer: a programmatic approach. Methods in molecular biology (Clifton, N.J.) 2013; 980.

Amin S, Lucas AL, Frucht H. Evidence for Treatment and Survival Disparities by Age in Pancreatic Adenocarcinoma: A Population-Based Analysis. ]. Pancreas 2012 Jul 24 [;.

Lucas AL, Hwang C, Frucht H. Strengthening the case for stool DNA tests as first-line colorectal cancer screening: are we there yet? [review]. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2012 Mar; 10(3).

Amin S, McBride R, Mitchell E, Lucas AL, Neugut A, Frucht H. Incidence of Subsequent Pancreatic Adenocarcinoma in Patients with a History of Nonpancreatic Primary Cancers.. Cancer 2012; 118(5): 1244-51.

Gonda TA, Lucas AL, Saif MW. Screening and detection of pancreatic cancer. Highlights from the [review]. JOP : Journal of the pancreas 2011 Jul; 12(4).

Swaminath A, Lucas AL, Capiak K, Sethi A, Garcia-Carrasquillo R. A foreign body larger than the overtube diameter: a case of a large cow foot bone causing esophageal impaction.. Gastroenterology and Hepatology : 2010; ;6(12): 793-5. .

Lucas A, Petrylak DP. The case for early chemotherapy for the treatment of metastatic disease [review]. The Journal of urology 2006 Dec; 176(6 Pt 2).

Hassid B, Lucas AL, Salomao M, Weng C, Liu F, Khanna LG, Kumar S, Hwang C, Chabot JA, Frucht H. Absence of Pancreatic Intraepithelial Neoplasia (PanIN) Predicts Poor Survival Following Resection of Pancreatic Cancer. [abstract]. Pancreas. 2014;.

Becker AE, Hernandez YG, Frucht H, Lucas AL. Pancreatic Ductal Adenocarcinoma: Risk Factors, Screening and Early Detection.. World J Gastroenterol 2014 August 28; 20(32): 11182.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Lucas did not report having any of the following types of financial relationships with industry during 2013 and/or 2014: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central

Address

Annenberg Building Floor 5 Room 12-D
1468 Madison Avenue
New York, NY 10029

Tel: 212-241-0150

Address

Faculty Practice Associates Floor 11
5 East 98th Street
New York, NY 10029

Tel: 212-241-4299
Faculty Practice Associates (Patient Office)

Division of Gastroenterology
5 East 98th Street, 11th Floor
New York, NY 10029

Tel: 212-241-4299
Fax: 212-426-5099
Get Directions

Office Hours:
  • Monday 9:00am - 5:00pm
  • Tuesday 9:00am - 5:00pm
  • Wednesday 9:00am - 5:00pm
  • Thursday 9:00am - 5:00pm
  • Friday 9:00am - 5:00pm
Languages:
  • Spanish
  • Russian
Insurance Plans
  • 1199 Member Choice
  • Beech Street
  • Island Group
  • MetroPlus Health Plan
  • PHCS
  • Pomco
  • Travel Care Services
  • United Health - PPO
  • United Health Care - Mount Sinai Top Tier
  • United Health Care Empire Plan
Payment Methods
  • Master Card
  • Visa
  • Personal Check
  • Cash